Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Denmark is investigating reports of blood clots after AstraZeneca COVID-19 vaccinations

By Sean Whooley | March 11, 2021

AstraZenecaThe Danish Medicines Agency announced that it is investigating the AstraZeneca COVID-19 vaccine after reports of blood clots.

In collaboration with the European Medicines Agency, the Danish Medicines Agency launched the investigation as it considers there to be a reason to look into the circumstances further after cases in which citizens developed blood clots shortly after being vaccinated. One report relates to a death, according to a news release.

Denmark’s National Board of Health has suspended further vaccinations in the country with AstraZeneca’s vaccine until the study results are available out of precaution. The EMA recently stated that there is no indication the vaccine is related to the blood clots, though, according to a BBC report.

“We do not yet know whether the blood clots and the Danish death are due to the vaccine, but it must now be thoroughly examined for safety,” Danish Medicines Agency unit manager Tanja Erichsen said in the release.

The agency warned citizens who have been vaccinated with AstraZeneca’s vaccine within the last 14 days and experienced prolonged symptoms that they should go to the doctor. Those with new symptoms within 14 days should also contact a doctor.

AstraZeneca’s vaccine has been put on hold in other countries, including Denmark’s neighbors, Norway and Iceland. Others have suspended use, too, including South Africa, which last month halted the vaccine’s use after a small study showed it was ineffective against a COVID-19 variant widely circulating there.


Filed Under: Drug Delivery, Drug Discovery, Drug Discovery and Development, Infectious Disease
Tagged With: AstraZeneca, coronavirus, covid-19, COVID-19 vaccine
 

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE